![Sam Tsimikas Profile](https://pbs.twimg.com/profile_images/1076890557870333952/uX7ZnYwN_x96.jpg)
Sam Tsimikas
@OxPL_apoB
Followers
2K
Following
22
Statuses
234
All things OxPL, @Lpa_doc
San Diego, CA
Joined December 2018
For those interested in research studies, OxPL-apoB and OxPL-apo(a) are now be available at Medpace. We will continue doing the tests @UCSanDiego for academic collaborations. For clinical care, OxPL-apoB is available @BostonHeartDX
0
1
2
No, Lp(a) is a risk factor, not a disease, therefore, it has no sxs until the disease starts (CAD, stroke, etc). That is why it is important to identify and treat early.
If a person with high Lp(a) of 219mnol/(88mg/dL) starts taking a PCSK9 inhibitor - will that person "feel" a difference? Given that person in already on a statin with cholesterol panel in range except high non-HDL @PeterAttiaMD @OxPL_apoB
2
0
6
Dr Constantinides was an MD/PhD pathologist. Being ahead of your time is good in retrospect, but not at that moment when you can't convince more people of the importance of your findings. Its that for many things in life, timing is a big part of succcess and progress....
0
0
0
Answers are in: 75% got it right- C. Note in the figure of a ruptured plaque how little apoB is present (noted by antibody MB47 that stains it) vs how many macrophages, OxPL (E06), Lp(a) (LPA4) and OxLDL (MDA2/IK17). Bottom line, inflamed lesions = ⏫ OxPL>OxLDL>Lp(a), ⏬ apoB
19/20 and the quiz: What is the correct statement: A- apoB accumulates as lesions progress B- Lp(a) diminishes as lesions progress C- OxPL accumulates and peaks at plaque rupture stage D- Answer please
0
2
6